Download Your Copy of the Agenda
Discover the scientific founders, clinical innovators, and industry leaders advancing next-generation cell therapies for autoimmune disease at the 4th Cell Therapy for Autoimmune Disease Summit.
Inside, you'll find full details of the "Moving Beyond CD19 to Identify the Next-Generation of Clinically Viable Targets" workshop, exploring how developers are uncovering novel autoimmune targets, leveraging AI-driven discovery approaches, and translating learnings from broader immunology to expand the therapeutic potential of cell therapy.
Dive into sessions exploring how emerging autologous, allogeneic, and in vivo approaches are being positioned to deliver durable immune reset, alongside insights into how Sail Biomedicines is advancing in vivo CD19 CAR-T engineering and how Artiva Biotherapeutics is progressing deep B-cell depletion strategies toward late-stage development.
Having trouble downloading the brochure? Let us know and we’ll email it to you instead.